Cancer #3 Flashcards
Carcinomas
cancers that a rise from epithelial cells
~ 90% of cancers
~ solid
Sarcomas
cancers that originate in supporting tissues
e.g. bone (osteo), fibrous tissue (fibre) or muscle (myo)
~ solid
Leukemias
cancer of leukocytes, malignant blood cells that proliferate in the blood stream
~ liquid
Lymphomas
cancers of lymphocytes, typically form solid masses in lymph nodes
~ liquid
Driver gene mutation
mutation that directly or indirectly confers a selective growth advantage to the cell in which it occurs
(cancer requires a collection, 5-8, of driver mutations)
Passenger mutation
mutation that has no direct or indirect effect on the selective growth advantage of the cell in which it occurred
What are the four most important properties of cancer cells? (can be caused by oncogene activation)
~ self-sufficiency in growth signallung ~ insensitivity to signals suppressing growth ~ enabling replicative immortality ~ genome instability and mutation ~ ability to avoid apoptosis
What is the common characteristic found in cancer susceptibility genes?
genes have roles as +ve or -ve regulators of cell proliferation
Oncogenes
dominantly acting cancer-susceptibility genes
~ normally protons-oncogenes
~ arise from genetic change that increases in the protein’s activity
~ mutations are genetically dominant
Proto-oncogene
function in growth signalling pathways that promote cell proliferation or inhibit apoptosis
Name the six functional classes of cellular oncogenes.
~ growth factors/mitogens ~ growth factors/mitogen receptors ~ signal transduction component ~ transcription factors ~ cell cycle regulators/drivers ~ cell death inhibitors
Mitogens
stimulate cell division by binding to a receptor in the cell membrane and activating signal transduction pathways that acts through Ras to stimulate
growth factors/mitogen receptors oncogenic mutations e.g. EGFR
EGFR = epidermal growth factor receptor
Very common in lots of cancers, mutations include:
~ amplification = more receptors
~ deletion = truncated reporter that fires w/o mitogen
signal transduction component oncogenic mutations
mutated Ras looses its intrinsic GTPase activity = permanently active = constant downstream signally w/o activation
transcription factors oncogenic mutations
Mutation in Myc protein:
~ amplification (lots of gene)
~ point mutation (stabilises Myc)
~ translocation (increased gene expression)
cell cycle regulators/drivers oncogenic mutations
~ CCND1 gene encodes Cyclin D –> its amplification is involved in lots of cancers as it promotes UNSCHEDULED entry into S phase
~ Over amplification of CDK4 gene (Cdk4) also found in many cancers
cell death inhibitors oncogenic mutations
~ increased Bax production (due to p53 activation) = Bax dimers and induction of apoptosis
~ amplification of Mdm2 = more MDM2 = no p53 accumulation = no activation of DNA damage checkpoint
Myc protein
acts in nucleus to stimulate cell growth and division
Myc protein
acts in nucleus to stimulate cell growth and division
Apoptosis
programmed cell death
~ controlled by Bcl2 family of proteins
~ EXTRINSIC (extracellular signalling proteins) or INTRINSIC (intracellular mitochondrial proteins) pathway
Apoptosis
programmed cell death
~ controlled by Bcl2 family of proteins
~ EXTRINSIC (extracellular signalling proteins) or INTRINSIC (intracellular mitochondrial proteins) pathway
MDM2 mechanism
no DNA damage = MDM2 ubiquitinates P53 (targets it for degradation)
DNA damage = MDM2 + p53 are phosphorylated = p53 accumulation
MDM2 mechanism
no DNA damage = MDM2 ubiquitinates P53 (targets it for degradation)
DNA damage = MDM2 + p53 are phosphorylated = p53 accumulation
Hayflick limit
normal cells in culture cease to divide after 50-70 doublings